- Report
- August 2025
- 187 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- October 2024
- 182 Pages
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- February 2025
- 100 Pages
Global
From €5252EUR$5,950USD£4,584GBP
- Report
- December 2024
- 100 Pages
Global
From €5252EUR$5,950USD£4,584GBP
- Report
- August 2025
- 181 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 188 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 184 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 196 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 190 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 194 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 180 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 198 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 186 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 188 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 194 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- August 2025
- 192 Pages
Global
From €3129EUR$3,545USD£2,731GBP
€3477EUR$3,939USD£3,035GBP
- Report
- September 2025
- 250 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- September 2025
- 250 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- September 2025
- 250 Pages
Global
From €3963EUR$4,490USD£3,459GBP
- Report
- July 2025
- 175 Pages
Global
From €3963EUR$4,490USD£3,459GBP

The Anxiety Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat anxiety disorders. Anxiety drugs are typically prescribed to treat a variety of conditions, including generalized anxiety disorder, panic disorder, social anxiety disorder, and post-traumatic stress disorder. Commonly prescribed anxiety drugs include benzodiazepines, selective serotonin reuptake inhibitors (SSRIs), and tricyclic antidepressants.
Anxiety drugs are typically prescribed by a doctor or mental health professional. The drugs are usually taken orally, although some may be administered intravenously or intramuscularly. The dosage and duration of treatment vary depending on the individual's condition and response to the drug.
Some of the major companies in the Anxiety Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca, and Johnson & Johnson. These companies produce a variety of anxiety drugs, including benzodiazepines, SSRIs, and tricyclic antidepressants. Show Less Read more